Molecular Therapy — Methods & Clinical Development: review time and acceptance speed

ISSN 2329-0501 · Cell Press · Biochemistry, Genetics and Molecular Biology

Half of the articles Molecular Therapy — Methods & Clinical Development accepted in 2025 were accepted within 159 days of submission (n = 191); the middle half took 114–206 days.

Submission → acceptance (2025)
159 days median
middle half 114–206 · n = 191
Acceptance → online
4 days median
middle half 3–5 · n = 191
Change since 2023
No clear change since 2023 (median 155 → 159 days; 90% CI -10 to +19 days).
Open access · fees
Open access (DOAJ) · $3,900

Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026

Plan submissions to a deadline — free

How long does Molecular Therapy — Methods & Clinical Development take to accept a paper?

days0601201802402020: middle half 24–117 days752020n=2272021: middle half 94–172 days1292021n=1752022: middle half 91–188 days1462022n=1432023: middle half 111–210 days1552023n=1502024: middle half 102–211 days1502024n=1622025: middle half 114–206 days1592025n=191
Line = median; shaded box = middle half of articles (25th–75th percentile). Year of acceptance.
Days from submission to acceptance, by year of acceptance
YearArticles (n)25th pctMedian75th pct90th pctAccepted <14 daysHave a revised date
20251911141592060.0%0%
20241621021502110.0%0%
20231501111552100.0%0%
2022143911461880.7%0%
2021175941291721.1%12%
2020227247511715110.1%2%

Distribution in 2025

0–29 days: 0% (0 articles)030–59 days: 3% (6 articles)3060–89 days: 10% (19 articles)6090–119 days: 16% (30 articles)90120–149 days: 15% (28 articles)120150–179 days: 19% (37 articles)150180–209 days: 13% (25 articles)180210–239 days: 9% (17 articles)210240–269 days: 4% (7 articles)240270–299 days: 5% (9 articles)270300–329 days: 2% (4 articles)300330–359 days: 1% (1 articles)330360+ days: 4% (8 articles)360+days from submission to acceptance (30-day bins)
Show as a table
DaysArticlesShare
0–2900.0%
30–5963.1%
60–89199.9%
90–1193015.7%
120–1492814.7%
150–1793719.4%
180–2092513.1%
210–239178.9%
240–26973.7%
270–29994.7%
300–32942.1%
330–35910.5%
360+84.2%

From acceptance to online publication

After acceptance, half of the 2025 articles appeared online within 4 days (middle half 3–5 days, n = 191).

From submission to online publication, the median was 164 days (middle half 118–209 days, n = 191).

Read these numbers carefully

  • These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
  • Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
  • Invited articles and special issues can move faster than regular submissions.

Open access status and publishing fees

Open access (listed in DOAJ). Listed APC: $3,900 (DOAJ).

Institutions reported paying a median of about $3,865 per article (2023–2025, 8 reported payments in OpenAPC; converted from euros at yearly ECB average rates).

Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.

Integrity and indexing signals

Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.

Listed in DOAJYes (DOAJ record)
Articles indexed for MEDLINE in 2025None found (the journal may be in PubMed through PubMed Central instead)
Retractions0 retracted articles among 897 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database.
Accepted within 14 days of submission0.0% of 2025 articles
Publication volume217 articles added to PubMed in 2025 (+33% vs 2024).

Topics and scope

Biochemistry, Genetics and Molecular Biology journalsMedicine journalsMolecular Biology journalsGenetics journals

Similar journals — faster or cheaper, side by side

Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2025 figures are compared with the 2025 median of Molecular Therapy — Methods & Clinical Development, 159 days.

Paid APC medianDOAJMEDLINE
Gene Therapy169 (2025, n = 71)≈$3,790NoYes
Molecular Therapy146 (2025, n = 558)≈$4,500$4,012 (6 payments)NoYes
Current Gene Therapy98 (2025, n = 71)NoYes
Cancer Gene Therapy146 (2025, n = 116)≈$4,990NoYes
The Journal of Gene Medicine96 (2025, n = 59)≈$4,480NoYes
Molecular Therapy Oncology165 (2025, n = 116)$3,900YesNo
Virology89 (2025, n = 277)≈$3,160NoYes

Frequently asked questions

How long does Molecular Therapy — Methods & Clinical Development take to accept a paper?

Half of the articles Molecular Therapy — Methods & Clinical Development accepted in 2025 were accepted within 159 days of submission (n = 191); the middle half took 114–206 days. Based on dates in PubMed for accepted articles only.

How long after acceptance are Molecular Therapy — Methods & Clinical Development articles published online?

Half of the articles accepted in 2025 appeared online within 4 days of acceptance (n = 191).

Does Molecular Therapy — Methods & Clinical Development charge an article processing charge (APC)?

Listed APC: $3,900 (DOAJ).

Sources and method

Journal identity: ISSN-L 2329-0501; NLM ID 101624857; OpenAlex record. Speed figures use 191 articles accepted in 2025 with valid dates; excluded records for that year: none.

Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.

Get the free Journal Submission Go/No-Go Checklist

The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.

One email with your download, then occasional research tips. One-click unsubscribe, anytime. We never sell your data.

Get Write and Publish a Scientific Paper

Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.